Literature DB >> 26423762

Effectiveness of reporting on latent tuberculous infection in Massachusetts, 2006-2008.

N S Hochberg1, R W Kubiak2, A Tibbs3, H Elder2, S Sharnprapai3, S Etkind3, C R Horsburgh2.   

Abstract

Massachusetts is one of five states that mandate the reporting of latent tuberculous infection (LTBI). We assessed 2006-2008 Massachusetts surveillance data for LTBI to describe the system and examine the characteristics of persons with LTBI. Over 3 years, 15 301 LTBI cases were reported (4742-5398/year). Among those with known country of birth (n = 11 655), 9983 (85.7%) were foreign-born. Substantial under-ascertainment and/or under-reporting appear likely; mandatory reporting does not appear sufficient for LTBI detection. Enhanced targeted testing, active LTBI surveillance, or laboratory-based surveillance may be needed to eliminate tuberculosis disease in the United States.

Entities:  

Keywords:  epidemiology; interferon-gamma release test; surveillance; tuberculin test

Year:  2014        PMID： 26423762      PMCID： PMC4479103          DOI： 10.5588/pha.13.0085

Source DB:  PubMed          Journal:  Public Health Action        ISSN： 2220-8372


  5 in total

1.  Priorities for screening and treatment of latent tuberculosis infection in the United States.

Authors:  Benjamin P Linas; Angela Y Wong; Kenneth A Freedberg; C Robert Horsburgh
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

2.  Three months of rifapentine and isoniazid for latent tuberculosis infection.

Authors:  Timothy R Sterling; M Elsa Villarino; Andrey S Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E Weis; Marc Weiner; Diane Wing; Marcus B Conde; Lorna Bozeman; C Robert Horsburgh; Richard E Chaisson
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

3.  Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.

Authors:  Diane E Bennett; Jeanne M Courval; Ida Onorato; Tracy Agerton; Judy D Gibson; Lauren Lambert; Geraldine M McQuillan; Brenda Lewis; Thomas R Navin; Kenneth G Castro
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

4.  Priorities for the treatment of latent tuberculosis infection in the United States.

Authors:  C Robert Horsburgh
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

5.  Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.

Authors:  Kimberly M Shea; J Steve Kammerer; Carla A Winston; Thomas R Navin; C Robert Horsburgh
Journal:  Am J Epidemiol       Date:  2013-10-18       Impact factor: 4.897
  5 in total
  3 in total

1.  Solid Organ Transplant-Transmitted Tuberculosis Linked to a Community Outbreak - California, 2015.

Authors:  Alexander Kay; Pennan M Barry; Pallavi Annambhotla; Carol Greene; Martin Cilnis; Peter Chin-Hong; Nicholas Arger; Louise McNitt; Nikole Neidlinger; Neha Shah; Sridhar V Basavaraju; Matthew Kuehnert; Tambi Shaw
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-08-04       Impact factor: 17.586

Review 2.  Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review.

Authors:  Mohsen Malekinejad; Andrea Parriott; Amanda P Viitanen; Hacsi Horvath; Suzanne M Marks; James G Kahn
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

3.  Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010-2014.

Authors:  J A Majerovich; L Fernandes; M Varia
Journal:  Can Commun Dis Rep       Date:  2017-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.